pleural effusion
TRANSCRIPT
PLEURAL EFFUSION
Dr Nirav Dhinoja
INTRODUCTION
There is normally a very thin layer of fluid (from 2 to
10 µm thick) between the two pleural surfaces, the
parietal pleura and visceral pleura.
The pleural space and the fluid within it are not
under static conditions.
During each respiratory cycle the pleural pressures
and the geometry of the pleural space fluctuate
widely. Fluid enters and leaves the pleural space
constantly.
The serous membrane covering the lung parenchyma is called the visceral pleura.
The remainder of the lining of the pleural cavity is the parietal pleura.
The parietal pleura receives its blood supply from the systemic capillaries.
The visceral pleura is supplied predominantly by branches of the bronchial artery in humans
The lymphatic vessels in the parietal
pleura are in direct
communication with the pleural space by
means of stomas.
These stomas are the only route through
which cells and large particles can leave
the pleural space.
Although there are abundant lymphatics
in the visceral pleura, these lymphatics
do not appear to participate in the
removal of particulate matter from the
pleural space.
MECHANISM OF PLEURAL FLUID TURNOVER
Dependent on the hydrostatic and oncotic pressures across membranes.
When the capillaries in the parietal pleura are considered, it can be seen that the net hydrostatic pressure favoring the movement of fluid from these capillaries to the pleural space is the systemic capillary pressure (30cm H2O) minus the negative pleural pressure (-5cm H2O) or 35cm H2O.
Opposing this is the oncotic pressure in the blood (34cm H2O) minus the oncoticpressure in the pleural fluid (5 cm H2O), or 29cm H2O.
The resulting net pressure differences of 6 cm H2O (35-29) favors movement of fluid from the parietal pleura into the pleural space.
Parietal Pleura Visceral
Pleura Space Pleura
Hydrostatic Pressure
+30 - 5 + 24
35 29
6 0
Net
29 29
+ 34 + 5 +34
Oncotic Pressure
NORMAL COMPOSITION PLEURAL FLUID
Volume 0.2 mL/kg
Cells/ mm3 1000 – 5000 Mesothelial cells 60%
Monocytes 30%
Lymphocytes 5%
PMN’s 5%
Protein 1-2 g/dL
LDH <50% plasma level
Glucose plasma level
pH ≥ plasma level
PATHOPHYSIOLOGY
Pleural fluid will accumulate when the rate of pleural fluid formation is greater than the rate of pleural fluid removal by the lymphatics.
Pleural effusions have classically been divided into Transudative
Exudative
A transudative pleural effusion occurs when
alterations in the systemic factors that influence
pleural fluid movement result in a pleural effusion.
Ex. Heart failure, nephrotic syndrome, hepatic
cirhosis.
Exudative pleural effusions occur when the pleural
surfaces are altered. Ex. Pleurisy.
ETIOLOGY
Elevated pleural capillary pressure :
Congestive heart failure, pericardial disease.
Elevated pleural permeability :
Pleural inflammation, neoplastic pleural disease (metastatic disease or mesotheliomas), pulmonary emboli, systemic lupus erythematosus (SLE).
Decreased serum oncotic pressure :
Cirrhosis, nephrotic syndrome, myxedema.
Dysfunction of parietal pleura lymphatics drainage.
Trauma, such as esophageal perforation, post-cardiac injury syndrome.
CLINICAL FEATURES
Many patients have no symptoms due to the effusion when effusion is small.
Pleuritic chest pain is the usual symptom of pleural inflammation.
Irritation of the pleural surfaces may also result in a dry, nonproductive cough.
With larger effusions, dyspnea results from lung compression.
PHYSICAL EXAMINATION
Signs are proportional to amount of effusion.
Fullness of intercostal spaces.
Decreased or absent tactile fremitus.
Dullness to percussion.
Diminished breath sounds over the site of the effusion.
Change in findings with change in position.
Signs of pneumonia like bronchial breathing,cracklesetc.
CHEST XRAY
The first fluid accumulates in the lowest portion of the thoracic
cavity, which is the posterior costophrenic angle.
The earliest radiologic sign of a pleural effusion is blunting of
the posterior costophrenic angle on the lateral chest
radiograph.
If a posteroanterior radiograph is obtained with the patient
lying on the affected side, free pleural fluid will gravitate
inferiorly and a pleural fluid line will be visible.
Pleural fluid is loculated when it does not shift freely in the pleural space as the patient’s position is changed.
Loculated pleural effusions occur when there are adhesions between the visceral and parietal pleurae.
Both ultrasound and computed tomography (CT) have useful in making this differentiation.
USG THORAX
CT CHEST
Should thoracentesis be performed?
If thoracentesis is done
Is the fluid a transudate or exudate?
If the fluid is an exudate
What is the etiology?
SHOULD THORACENTESIS BE PERFORMED?
Most patients should be tapped Newly recognized effusion.
Two exceptions Small Effusions ( < 1 cm on decubitus)
Congestive Heart Failure Thoracentesis only if bilateral effusions not equal.
Fever.
Pleuritic chest pain.
Impending respiratory faillure.
Is The Fluid A Transudate Or Exudate?
Transudative Effusions Mechanical
No capillary leak or cytokine activation
Excessive formation or impaired absorption
Limits the differential with no additional workup CHF, Cirrhosis, or Nephrotic Syndrome
If Exudative, more investigation required
Method: LIGHT’s Criteria
LIGHT’S CRITERIA (EXUDATE)
Pleural fluid total protein/ serum protein >0.5
Pleural total protein > 3g/dl.
Pleural fluid LDH/serum LDH > 0.6
Pleural fluid LDH > 200 IU/l.
Pleural fluid LDH level > 2/3 of upper normal
level of serum LDH.
EFFUSIONS
Congestive Heart Failure
Nephrotic syndrome
Cirrhosis
Meig’s Syndrome
Hydronephrosis
Peritoneal Dialysis
Parapneumonic
Malignancy
Pulmonary Embolism
Tuberculosis
Traumatic
Collagen Vascular (SLE, RA)
Drug induced, Uremia, Dressler’s syndrome
Transudate Exudate
OTHER USEFUL TESTS
Brain Natriuretric Peptide (N<1000 pg/mL)
> 1000 in CHF
Glucose < 60 mg/dL
Empyema or Rheumatoid Arthritis
pH < 7.2 Empyema
Triglycerides > 110 mg/dL
Chylothorax
Amylase
Malignancy, Pancreatic disease.
OTHER USEFUL TESTS
Pleural to blood Hct > 0.5
Hemothorax
Cell Count
PMN predominate in parapneumonic pneumonia.
Lymphocyte predominate in malignancy, Tb, CABG.
The pleural fluid ADA level above 45 IU/L - tuberculous pleuritis.
Fluid Culture
Grams stain, bacterial culture, acid fast bacilli smear and culture,
and fungal culture.
Cytology for malignancy.
PLEURAL FLUID MANAGEMENT
Observation Defervesce quickly Uncomplicated pleural effusion
Therapeutic drainage (thoracentesis) Early exudative phase
Tube thoracostomy Complex pleural fluid spaces
VATS (Video assisted thoracoscopic surgery) Poor clinical response to above interventions
Decortication: removal of pleural peel
Parapneumonic effusion Any pleural effusion associated with bacterial or
viral pneumonia
Loculated parapneumonic effusion Not free flowing
Multiloculated parapneumonic effusion Noncommunicating compartments
Empyema (fibrosuppurative exudate) Pus in the pleural space.
pH < 7.2, Glucose < 60 mg/dL, High LDH.
EMPYEMA
Empyema is an accumulation of pus in the pleural
space.
It is most often associated with pneumonia.
It can also be produced by :
Rupture of a lung abscess into the pleural space.
Contamination introduced from trauma or thoracic
surgery.
Mediastinitis or the extension of intra-abdominal
abscesses.
ETIOLOGY EMPYEMA
Infectious Pneumonias
Staph aureus
Strep pneumonia
Gram negative bacilli
Tuberculous pleuritis
Thoracic trauma
Severe Sepsis
NATURAL HISTORY EMPYEMA
Exudative stage Rapid accumulation of inflammatory fluid
Normal pH, Glucose, and LDH level
Antibiotics effective
Fibropurulent stage PMN’s, Fibrin deposition, loculations occur
Low pH and glucose, high LDH
Organization stage (fibrothorax) Fibroblast proliferation between pleural layers
Pleural peel develops, decortication required
CLINICAL FEATURES
Primary signs & symptoms of pneumonia.
Most patients are febrile, develop increased work of
breathing or respiratory distress, and often appear
more ill.
Physical findings are similar to effusion.
DIAGNOSIS
Similar to other effusion radiologically.
Pleural fluid analysis is must to differentiate.
Characteristic of pus :
Bacteria are present on Gram staining.
pH is <7.20.
>100,000 neutrophils/µL.
Pleural fluid culture & PCR analysis to identify
organism.
TREATMENT
Systemic antibiotics.
Depends on culture & sensitivity report.
2 weeks of IV antibiotics.(in staphylococci infection
response is very slow so required for 3-4wks.)
Closed tube drainage.
VATS
Open decortication.
TREATMENT
In the child who remains febrile and dyspneic >72
hr after initiation of therapy with intravenous
antibiotics and thoracostomy tube drainage,
surgical decortication via VATS or open
thoracotomy may speed recovery.
If pneumatoceles form, no attempt should be made
to treat them surgically or by aspiration, unless they
reach cause respiratory embarrassment or become
secondarily infected.
COMPLICATIONS
Local
Bronchopleural fistula.
Pyopneumothorax.
Purulent pericarditis.
Pulmonary abscesses.
Peritonitis from extension
through the diaphragm.
Osteomyelitis of the ribs.
Systemic
Septicemia.
Meningitis
Arthritis.
Osteomyelitis.